Mobile Mammography Promotion Act of 2015

P.L.111-148, Patient Protection and Affordable Care Act, matters related to the Implementation of breast health education, research and clinical trials. H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients. H.R.1628, American Health Care Act, advocate for inclusion of patient protections. H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies; H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings. S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

P.L.111-148, Patient Protection and Affordable Care Act, matters related to the Implementation of breast health education, research and clinical trials. H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients. H.R.1628, American Health Care Act, advocate for inclusion of patient protections. H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography; H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies; S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings. S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.

Client expense: $47,535 · Firm income: Not reported

Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.

Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.

Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.

Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.

Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; S.1926/H.R.3339, Protecting Access to Lifesaving Screenings Act, amends Title XVIII of the Social Security Act to protect coverage for screening mammography; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care.

H.R. 216, the Department of Veterans Affairs Budget Planning Reform Act of 2015 H.R. 218, the CHAMPVA Childerns Protection Act of 2015 H.R. 271, the Creating Options for Veterans Expedited Recovery Act H.R. 303, the Retired Pay Restoration Act H.R. 627, to expand the VAs definition of homeless to match the definition used by the Department of Housing and Urban Development (HUD) since 1987 H.R. 675, the Veterans Compensation Cost-of-Living Adjustment Act of 2015 H.R. 677, the American Heroes COLA Act of 2015 H.R. 732, the Veterans Access to Speedy Review Act H.R. 1067, the U.S. Court of Appeals for Veterans Claims Reform Act H.R. 1302, the VA Appeals Backlog Relief Act H.R. 1331, the Quicker Veterans Benefits Delivery Act of 2015 H.R. 1338, the Dignified Interment of Our Veterans Act of 2015 H.R. 1369, the Veterans Access to Extended Care Act of 2015 H.R. 1379 to modify the remand process H.R. 1380 to expand the eligibility for a medallion furnished by the Secretary to signify the veteran status of a deceased individual H.R. 1384, the Honor Americas Guard-Reserve Retirees Act H.R. 1414, the Pay As You Rate Act H.R. 1569 to clarify that the estate of a deceased veteran H.R. 1575 to make permanent the pilot program on counseling in retreat settings for women veterans newly separated from service in the Armed Forces H.R. 1607, the Ruth Moore Act of 2015 H.R. 1994/ S. 1082, the VA Accountability Act of 2015 H.R. 2001, the Veterans 2nd Amendment Protection Act H.R. 2133, the Servicemembers Choice in Transition Act H.R. 2214, the Disabled Veterans Access to Medical Exams Improvement Act H.R. 2605, the Veterans Fiduciary Reform Act of 2015 H.R. 2691, the Veterans Survivors Claims Processing Automation Act of 2015 H.R. 2706, the Veterans National Remembrance Act Draft legislation to provide assisted reproductive technology (ART) to certain disabled veterans The Toxic Exposure Research Act of 2015 H.R. 356, the Wounded Warrior Employment Improvement Act H.R. 832, the Veterans Employment and Training Service Longitudinal Study Act of 2015 H.R. 2275, the Jobs for Veterans Act of 2015 H.R. 2360, the Career-Ready Student Veterans Act H.R. 2361, the Work-Study for Student Veterans Act S. 91, the Veterans ID Card Act S. 469, the Women Veterans and Families Health Services Act of 2015 S. 657, the Caregivers Expansion and Improvement Act of 2015 S. 207, the Veterans Access to Community Care Act S. 297, the Frontlines to Lifelines Act S. 425, the Homeless Veterans' Reintegration Programs Reauthorization Act of 2015 S. 471, the Women Veterans Access to Quality Care Act S. 684, the Homeless Veterans Prevention Act S. 901, the Toxic Exposure Research Act S. 1085 "Military and Veteran Caregiver Services Improvement Act of 2015" The Veterans Health Act of 2015 The Department of Veterans Affairs Purchased Health Care Streamlining and Modernization Act S. 1641, the Jason Simcakoski Memorial Opioid Safety Act S. 1117, the Ensuring Veteran Safety Through Accountability Act of 2015 The Biological Implant Tracking and Veteran Safety Act Implementation of P.L. 113-146, the Veterans Access, Choice, and Accountability